Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 28, 2024 - Issue 4
Submit an article Journal homepage
367
Views
0
CrossRef citations to date
0
Altmetric
Editorial

S100A1: a promising therapeutic target for heart failure

Dorothea Nolla Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany;b German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, GermanyView further author information
,
Dorothea Kehra Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany;b German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, GermanyView further author information
,
Patrick Mosta Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany;b German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany;c Center for Translational Medicine, Jefferson University, Philadelphia, PA, USAView further author information
&
Julia Ritterhoffa Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany;b German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, GermanyCorrespondence[email protected]
View further author information
Pages 233-236 | Received 08 Jan 2024, Accepted 17 Apr 2024, Published online: 22 Apr 2024
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Declaration of interest

P Most and D Kehr hold patents on the therapeutic use of S100A1 in cardiovascular diseases. P Most is the founder of AaviGen GmbH.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This work was supported in part by grants of the German Cardiovascular Research Center [DZHK 81Z0500101 to PM], the Informatics For Life (Subproject 2) by the Klaus Tschira Stiftung.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.